Johnson Johnson Story

JNJ -- USA Stock  

USD 132.00  4.38  3.21%

Macroaxis News
By Vlad Skutelnik
This report is for traders who are contemplating to exit Johnson Johnson. I will concentrate on why it could still be a good year for Johnson Johnson traders. Here I will also examine some technical and fundamental indicators drivers that the stock investors should consider in March. We found thirty-eight available reported financial drivers for Johnson Johnson which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Johnson Johnson fundamentals including its Total Debt, Market Capitalization and the relationship between Gross Profit and Short Ratio . Given that Johnson Johnson has Price to Earning of 23.62X, we strongly advise you confirm Johnson Johnson regular market performance to make sure the company can sustain itself down the road. Use Johnson Johnson to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Johnson Johnson to be traded at $139.02 in 30 days.
Will Johnson Johnson continue to be wobbly?

The company is overvalued at 126.58 per share with modest projections ahead. The company retains Market Volatility (i.e. Beta) of 1.0417 which attests that Johnson Johnson returns are very sensitive to returns on the market. as market goes up or down, Johnson Johnson is expected to follow. Even though it is essential to pay attention to Johnson Johnson current price history, it is always good to be careful when utilizing equity current price movements. Macroaxis philosophy towards determining future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Johnson Johnson exposes twenty-one different technical indicators which can help you to evaluate its performance. Johnson Johnson has expected return of -0.2389%. Please be advised to check out Johnson Johnson Information Ratio as well as the relationship between Potential Upside and Kurtosis to decide if Johnson Johnson past performance will be repeated at some point in the near future.

Johnson Johnson has Return on Asset of 8.4 % which means that on every $100 spent on asset it made $8.4 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 24.52 % implying that it generated $24.52 on every 100 dollars invested. The recent Johnson Johnson price drops may raise some interest from investors. The Stock closed today at a share price of 131.54 on 4436718.000 in trading volume. The company executives were unable to exploit market volatilities in January. However, diversifying your overall positions with Johnson Johnson can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 2.4465. The current volatility is consistent with the ongoing market swings in January 2019 as well as with Johnson Johnson unsystematic, company specific events. Johnson Johnson defends 6.6 z score. Johnson Johnson is selling at 132.40. That is 0.27 percent up. Started trading at 132.40. Johnson Johnson Net Cash Flow from Operations is fairly stable at the moment. Also, Johnson Johnson Consolidated Income is fairly stable at the moment.

 2013 2014 2016 2018 2019 (projected)
Johnson Johnson Cost of Revenue 22,746,000,000  21,536,000,000  21,685,000,000  19,516,500,000  17,601,526,316 
Johnson Johnson Consolidated Income 16,323,000,000  15,409,000,000  16,540,000,000  14,886,000,000  12,576,026,316 

To sum up, we believe that at this point Johnson Johnson is not too risky with low probability of distress within the next 2 years. Our ongoing buy vs. sell advice on the organization is Hold.

Johnson Johnson Valuation

Enterprise Value

Johnson Johnson exotic insider transaction detected

Johnson Johnson insider trading alert for general transaction of common stock by Charles Prince, the corporate stakeholder, on December 17, 2018. This event was filed by Johnson Johnson with SEC on 2018-12-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

About Contributor

Vlad Skutelnik
   Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered as solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Johnson Johnson. Please refer to our Terms of Use for any information regarding our disclosure principles.

Story Momentum

This article from Macroaxis published on 11 of February did not cause price change. The trading delta at closing time when the story was published to current price is 0.23% .

Similar stores for Johnson Johnson

over a week ago at 
Gilead Sciences Holder Beck Mack Oliver Raised Stake Paragon Capital Management Position in Johnson Johnson In...
Capital Management Position in Johnson Johnson Increased as Market Valuation Rose The Hi New UlmBeck Mack Oliver Llc increased its stake in Gilead Sciences Inc by 1.74 percent based on its latest 2018Q3 regulatory filing with the SEC. Beck Mack Oliver ...
over a week ago at 
Johnson and Johnson will start listing drug prices in TV commercials - CNBC
cnbc News
Johnson and Johnson will start listing drug prices in TV commercials CNBCJohnson Johnson said Thursday it will start giving the list price of its prescription drugs in television ads. The company would be the first drugmaker to take that ...

Compare Johnson Johnson

Compare Johnson Johnson To Peers

Profit Margin

Profit Margin Comparative Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Please also check Risk vs Return Analysis. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.